The Elizabeth Blackwell Institute's Bristol Cancer Research Network will be hosting its annual Early Career Researchers' (ECRs) symposium on 28 June 2023. 

This half-day event will comprise oral and poster presentations from ECRs as well as keynote talks from two invited speakers.  

Aims of the event:

The Bristol Cancer Research Network's Early Career Researchers' event is a fantastic opportunity for Early Career Researchers to write and submit an abstract and strengthen their presentation skills to an audience of their peers. This is the perfect platform to share your work, explore alternative methodologies, ask questions if you feel one aspect of your research would benefit from wider input, offer expertise and encourage wider collaborations. This is your chance to take part in discussions that could lead to greater inter- and multidisciplinary understanding of the research in question and its potential relevance to other areas. Early-stage proposals are welcomed. 

The event is open to all; if you are not presenting, please attend and support our ECRs to gain a better understanding of the incredible breadth of research taking place across the wider Cancer community. 

This event aims to foster the creation of new research directions, new ways of working, new ways to support and enable our academic and clinical communities, and new learning experiences. 

What is an early career researcher (ECR)?

We have no set definition for an ECR; we welcome submissions from undergraduates, postgraduates, postdocs, technicians, recently appointed lecturers who are starting their academic careers, clinicians embarking on a research career, and anyone else who feels they are starting a new phase in their career journey.

Registration: is now CLOSED. Contact catherine.brown@bristol.ac.uk directly to see if spaces are still available. 

Call for abstracts: is now CLOSED

10.00	Helen Winter (Consultant Medical Oncologist, Clinical Director, Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance, and Cancer Network co-Lead)	Welcome and Introduction
	Session 1 Chair: Ridhi Bansal (PhD student, Department of Aerospace Engineering, University of Bristol)
10.05	Hannah Reed (ST5 Medical Oncology Registrar, University Hospitals Bristol and Weston NHS Foundation Trust)	Evaluating the Immunological Effects of Stereotactic Ablative Radiotherapy (SABR) in Patients with Oligometastatic and Primary Cancer
10.20	Marina Vabistsevits (PhD student, Bristol Medical School: Population Health Sciences, University of Bristol)	The mediating role of mammographic density in the protective effect of early-life adiposity on breast cancer risk
10.35	George Richenberg (PhD student, Bristol Medical School: Population Health Sciences, University of Bristol)	Germline genetically predicted body mass index is associated with endometrial cancer somatic transcriptomic, immune, and mutational signatures in The Cancer Genome Atlas
10.50	Katy Pinnell (MScR student, School of Cellular and Molecular Medicine, University of Bristol)	The roles of ZDHHC18 and ZDHHC4 in endothelial cell-mediated T-ALL cell attachment and transendothelial migration
11.05	Marc Gunter (Chair in Cancer Epidemiology and Prevention, School of Public Health, Imperial College London)	Obesity and Cancer: Causes, Mechanisms and Pathways to Prevention
11.30	Lunch and poster session
	Session 2 Chair: Amy Francis (PhD student, Bristol Medical School: Population Health Sciences, University of Bristol)
13.30	Hannah Kirk (Medical Oncology ST4, NIHR Academic Clinical Fellow, School of Cellular and Molecular Medicine, University of Bristol)	Investigating the effects of p21-activated kinase inhibitors on prostate cancer cells
13.45	Daniel Turnham (Research Associate, European Stem Cell Research Institute, Cardiff University)	Preclinical evaluation of a novel antibody drug conjugate for prostate cancer
14.00	Laura Perry (PhD student, School of Applied Sciences, University of the West of England)	Understanding and targeting the prostaglandin E2 receptor EP4 for cancer therapy
14.15	Zak Thornton (PhD Student, Bristol Medical School: Population Health Sciences, University of Bristol)	Multi-omics Mendelian randomisation using expression, protein and splicing quantitative trait loci: identification of novel drug targets associated with risk of gliomagenesis
14.30	Robert Jones (Professor and Consultant in Medical Oncology, Specialty Lead for Cancer in Wales, Early Phase Trials Lead, and Clinical Director of Research at Velindre Cancer Centre, School of Medicine, Cardiff University)	Navigating a path to link pre-clinical and clinical cancer research
14.55	Richard Martin (Professor of Clinical Epidemiology, Deputy Head of Bristol Medical School & Head of Population Health Sciences, University of Bristol and Cancer Network co-Lead)	Closing remarks

Posters:

• Abraham Manju (Research Associate, Engineering Mathematics / School of Cellular and Molecular Medicine, University of Bristol): Tackling drug resistance in non-small cell lung cancer via feedback system control
• Alhadrami Mai (PhD student, Bristol Medical School: Translational Health Sciences, University of Bristol): The role of amyloid precursor protein processing in IGF-induced proliferation in prostate cancer cells
• Biggs Sarah (ST4 General Surgery, Royal United Hospital Bath NHS Trust): Diagnostic pathways and symptomatology of colorectal cancer in young adults: results of the Somerset, Wiltshire, Avon and Gloucestershire Young-Onset Colorectal Cancer (SWAG-YOCC) Study
• Cook Harriet (FY1, Southmead Hospital, North Bristol NHS Trust): Neurotoxicity of Immune Checkpoint Inhibitors: A Case Series from Bristol Haematology and Oncology Centre
• Creavin Alexandra (ST2 Academic Clinical Fellow in Public Health, Bristol Medical School: Population Health Sciences, University of Bristol): Inequality in the uptake of bowel cancer screening across Bristol, North Somerset, and South Gloucestershire since COVID-19: a cross-sectional study of 86,850 citizens
• Ebrahimi Elmira (PhD student, International Agency for Research on Cancer): Discovering Genetic Susceptibility Loci for Head and Neck Cancer through the largest GWAS to date
• Gill Emily (PhD student, Bristol Medical School: Translational Health Sciences, University of Bristol): PLEKHS1: A novel link between Type 2 Diabetes, Obesity and Cancer?
• Gynn Liana (Lecturer in Biomedical Science School of Applied Science, University of the West of England): Alteration of cytarabine toxicity and secretome by bone marrow stromal and leukaemic cells in co-culture microenvironments
• Hoskin Ashley (PhD student, School of Cellular and Molecular Medicine, University of Bristol): The metabolic effect of 5-ASA on colorectal cancer development and progression
• Lavalou Jules (Research Associate, School of Cellular and Molecular Medicine, University of Bristol): Unmasking the competitive loser status of tumours with ribosomal mutations
• Li Haonan (PhD student, Bristol Medical School, University of Bristol): The role of IGFBP-2 and GRP78 in the proliferative effects of IGF-I in MCF-7 breast cancer cells
• McKeown-Keegan Sadie (Clinical Trials Manager/PPI Lead for the FAST MRI Programme, Research and Innovation, North Bristol NHS Trust): FAST MRI: Optimising training to improve diagnostic accuracy in abbreviated breast MRI
• Owen Carina (Academic Clinical Fellow in Medical Oncology ST5, Bristol Medical School: Population Health Sciences, University of Bristol): The association between polygenic risk of autoimmune disease, progression-free survival, and pathway-level transcriptomic signatures predictive of anti-PD1 response in melanoma
• Robles Luke (Senior Research Associate in Mixed Methods Cancer, NIHR Bristol Biomedical Research Centre, University of Bristol): Recruitment and adherence to physical activity and metformin interventions in men with prostate cancer: lessons learned from a factorial RCT
• Russell Helen (Research Associate, Bristol Medical School: Population Health Sciences, University of Bristol): Assessing the impact of additional rounds of breast cancer screening after the age of 64 on health outcomes using NHS Breast Screening Programme data
• Slater Kirsty (TYA Research Nurse, Clinical Trials Unit, University Hospitals Bristol and Weston NHS Foundation Trust): Improving Access for TYA Patients into Research
• Su Xiaoyu (PhD student, Bristol Medical School: Translational Health Sciences, University of Bristol): Investigating the role of ERβ and IGFBP5 in colorectal cancer

 

PARTNERS:

We grateful to the following for supporting this event:

Elizabeth Blackwell Institute for Health Research - Nurturing Research. Improving Health. 

Bristol Population Health Science Institute

Q‌iagen